171 related articles for article (PubMed ID: 81511)
1. Studies on the pancreatic secretory trypsin inhibitor in plasma and its complex with trypsin in vivo and in vitro.
Eddeland A; Ohlsson K
Scand J Clin Lab Invest; 1978 Oct; 38(6):507-15. PubMed ID: 81511
[TBL] [Abstract][Full Text] [Related]
2. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
[TBL] [Abstract][Full Text] [Related]
3. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
Marks WH; Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
[TBL] [Abstract][Full Text] [Related]
4. Partition of trypsin and Kazal inhibitor in reaction mixtures with human serum.
Eddeland A
Hoppe Seylers Z Physiol Chem; 1979 Feb; 360(2):145-9. PubMed ID: 422124
[TBL] [Abstract][Full Text] [Related]
5. On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
Balldin G; Borgström A; Marks WH; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):751-6. PubMed ID: 6207093
[TBL] [Abstract][Full Text] [Related]
6. Purification of canine pancreatic secretory trypsin inhibitor and interaction in vitro with complexes of trypsin-alpha-macroglobulin.
Eddeland A; Ohlsson K
Scand J Clin Lab Invest; 1976 Dec; 36(8):815-20. PubMed ID: 73214
[TBL] [Abstract][Full Text] [Related]
7. Elimination of pancreatic secretory trypsin inhibitor from the circulation. A study in man.
Marks WH; Ohlsson K
Scand J Gastroenterol; 1983 Oct; 18(7):955-9. PubMed ID: 6676929
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases.
Kitahara T; Takatsuka Y; Fujimoto KI; Tanaka S; Ogawa M; Kosaki G
Clin Chim Acta; 1980 Apr; 103(2):135-43. PubMed ID: 6154549
[TBL] [Abstract][Full Text] [Related]
9. The two alpha 2-macroglobulin-bound trypsin molecules have different affinities for the basic pancreatic trypsin inhibitor.
Tourbez M; Dimicoli JL; Pochon F; Bieth JG
Biochim Biophys Acta; 1984 Aug; 789(1):74-9. PubMed ID: 6205695
[TBL] [Abstract][Full Text] [Related]
10. Interactions of pancreatic secretory trypsin inhibitor in small intestinal juice: its hydrolysis and protection by intraluminal factors.
Freeman TC; Davies R; Calam J
Clin Chim Acta; 1990 Dec; 195(1-2):27-39. PubMed ID: 2093478
[TBL] [Abstract][Full Text] [Related]
11. In vivo metabolism of inter-alpha-trypsin inhibitor and its proteinase complexes: evidence for proteinase transfer to alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
Pratt CW; Pizzo SV
Arch Biochem Biophys; 1986 Aug; 248(2):587-96. PubMed ID: 2427028
[TBL] [Abstract][Full Text] [Related]
12. [Effects of pH on the formation and dissociation of the complex of trypsin and PSTI].
Seshimo T; Nohara T; Shikimi T; Nakase A
Nihon Shokakibyo Gakkai Zasshi; 1992 May; 89(5):1279-85. PubMed ID: 1377760
[TBL] [Abstract][Full Text] [Related]
13. Elevation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with serious injury.
Ogawa M; Matsuda K; Shibata T; Matsuda Y; Ukai T; Ohta M; Mori T
Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):259-66. PubMed ID: 2417295
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic secretory trypsin inhibitor immunoreactivity detected in serum-free culture medium of human pancreatic carcinoma cell line, CAPAN-1.
Ogata N; Murata A
Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):233-44. PubMed ID: 3358013
[TBL] [Abstract][Full Text] [Related]
15. Purification, characterization and amino-acid sequencing of two pancreatic secretory trypsin inhibitors in rat pancreatic juice.
Uda K; Ogawa M; Shibata T; Murata A; Mori T; Kikuchi N; Yoshida N; Tsunasawa S; Sakiyama F
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():55-61. PubMed ID: 3202973
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.
Niinobu T; Ogawa M; Murata A; Nishijima J; Mori T
J Exp Med; 1990 Oct; 172(4):1133-42. PubMed ID: 2170560
[TBL] [Abstract][Full Text] [Related]
17. The disappearance of enzyme-inhibitor complexes from the circulation of man.
Ohlsson K; Laurell CB
Clin Sci Mol Med; 1976 Jul; 51(1):87-92. PubMed ID: 59654
[TBL] [Abstract][Full Text] [Related]
18. A mutant trypsin-like enzyme from Streptomyces fradiae, created by site-directed mutagenesis, improves affinity chromatography for protein trypsin inhibitors.
Katoh T; Kikuchi N; Nagata K; Yoshida N
Appl Microbiol Biotechnol; 1996 Aug; 46(1):15-21. PubMed ID: 8987530
[TBL] [Abstract][Full Text] [Related]
19. Production of specific monoclonal antibodies against the active sites of human pancreatic secretory trypsin inhibitor variants by in vitro immunization with synthetic peptides.
Böldicke T; Kindt S; Maywald F; Fitzlaff G; Böcher M; Frank R; Collins J
Eur J Biochem; 1988 Aug; 175(2):259-64. PubMed ID: 3402453
[TBL] [Abstract][Full Text] [Related]
20. A radioimmunoassay for rat pancreatic secretory trypsin inhibitor.
Marks WH; Ohlsson K
Scand J Gastroenterol; 1983 May; 18(3):401-5. PubMed ID: 6673065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
